Paramagnetic self-assembled nanoparticles as supramolecular MRI contrast agents

Contrast Media and Molecular Imaging

Volumn 7, Issue 3, 2012, Pages 356-361

  Besenius, Pol ^a   Heynens, Joeri L M ^a   Straathof, Roel ^a   Nieuwenhuizen, Marko M L ^a   Bomans, Paul H H ^a   Terreno, Enzo ^b   Aime, Silvio ^b   Strijkers, Gustav J ^a   Nicolay, Klaas ^a   Meijer, E W ^a  

^a EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Bio nanotechnology; Functional materials; Imaging; Self assembly; Supramolecular oligomers

Indexed keywords

AMPHOPHILE; CONTRAST MEDIUM; GADOLINIUM PENTETATE; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OLIGOMER; PROTON; WATER;

ANIMAL EXPERIMENT; ARTERY; ARTICLE; BLOOD; BRAIN; CHEMICAL STRUCTURE; CONTRAST ENHANCEMENT; CRYOELECTRON MICROSCOPY; FLUORINATION; IMAGING; KINETICS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MATERIALS; MOLECULAR WEIGHT; MOUSE; NANOTECHNOLOGY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARTICLE SIZE; PRIORITY JOURNAL; SUPRAMOLECULAR CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY; VEIN;

ANIMALS; BRAIN MAPPING; CONTRAST MEDIA; GADOLINIUM DTPA; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; NANOPARTICLES;

EID: 84860388269     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.498     Document Type: Article

References (42)

1. Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 2010; 9(8): 615-627.
2. Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat Mater 2009; 8(1): 15-23.
3. Mulder WJM, Strijkers GJ, van Tilborg GAF, Cormode DP, Fayad ZA, Nicolay K. Nanoparticulate assemblies of amphiphiles and diagnostically active materials for multimodality imaging. Acc Chem Res 2009; 42(7): 904-914.
4. Jiang W, KimBetty YS, Rutka JT, Chan W. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 2008; 3(3): 145-150.
5. Farokhzad OC, Langer R. Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 2006; 58(14): 1456-1459.
6. Johnston APR, Cortez C, Angelatos AS, Caruso F. Layer-by-layer engineered capsules and their applications. Curr Opin Colloid Interface Sci 2006; 11(4): 203-209.
7. Wagner V, Dullaart A, Bock A-K, Zweck A. The emerging nanomedicine landscape. Nat Biotechnol 2006; 24(10): 1211-1217.
8. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA. Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 1997; 277(5329): 1078-1081.
9. Louie A Multimodality imaging probes: design and challenges. Chem Rev 2010; 110(5): 3146-3195.
10. Terreno E, Castelli DD, Viale A, Aime S. Challenges for molecular magnetic resonance imaging. Chem Rev 2010; 110: 3019-3042.
11. Villaraza AJL, Bumb A, Brechbiel MW. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics. Chem Rev 2010; 110: 2921-2959.
12. Merbach AE, Tóth É. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. Chichester: Wiley, 2001.
13. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99(9): 2293-2352.
14. Srikun D, Albers AE, Chang CJ. A dendrimer-based platform for simultaneous dual fluorescence imaging of hydrogen peroxide and pH gradients produced in living cells. Chem Sci 2011; 2: 1156-1165.
15. Welsher K, Liu Z, Sherlock SP, Robinson JT, Chen Z, Daranciang D, Dai H. A route to brightly fluorescent carbon nanotubes for near-infrared imaging in mice. Nat Nanotechnol 2009; 4(11): 773-780.
16. Soo Choi H, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, Bawendi MG, Frangioni JV. Renal clearance of quantum dots. Nat Biotechnol 2007; 25(10): 1165-1170.
17. Helms BA, Reulen SWA, Nijhuis S, de Graaf-Heuvelmans PTHM, Merkx M, Meijer EW. High-affinity peptide-based collagen targeting using synthetic phage mimics: from phage display to dendrimer display. J Am Chem Soc 2009; 131(33): 11683-11685.
18. Sun G, Xu J, Hagooly A, Rossin R, Li Z, Moore DA, Hawker CJ, Welch MJ, Wooley KL. Strategies for Optimized Radiolabeling of Nanoparticles for in vivo PET Imaging. Adv Mater 2007; 19(20): 3157-3162.
19. Shokeen M, Pressly ED, Hagooly A, Zheleznyak A, Ramos N, Fiamengo AL, Welch MJ, Hawker CJ, Anderson CJ. Evaluation of multivalent, functional polymeric nanoparticles for imaging applications. ACS Nano 2011; 5(2): 738-747.
20. Floyd WC, Klemm PJ, Smiles DE, Kohlgruber AC, Pierre VC, Mynar JL, Fréchet JMJ, Raymond KN. Conjugation effects of various linkers on Gd(III) MRI contrast agents with dendrimers: optimizing the hydroxypyridinonate (HOPO) ligands with nontoxic, degradable esteramide (EA) dendrimers for high relaxivity. J Am Chem Soc 2011; 133(8): 2390-2393.
21. Röglin L, Lempens EHM, Meijer EW. A synthetic 'tour de force': well-defined multivalent and multimodal dendritic structures for biomedical applications. Angew Chem Int Ed 2011; 50(1): 102-112.
22. Ali MM, Woods M, Caravan P, Opina ACL, Spiller M, Fettinger JC, Sherry AD. Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent. Chem Eur J 2008; 14(24): 7250-7258.
23. Langereis S, Dirksen A, Hackeng TM, Genderen MHP, Meijer EW. Dendrimers and magnetic resonance imaging. New J Chem 2007; 31: 1152-1160.
24. Kobayashi H, Brechbiel M. Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Del Rev 2005; 57(15): 2271-2286.
25. Lee CC, MacKay JA, Frechet JMJ, Szoka FC. Designing dendrimers for biological applications. Nat Biotechnol 2005; 23(12): 1517-1526.
26. Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994; 31: 1-8.
27. Bull SR, Guler MO, Bras RE, Meade TJ, Stupp SI. Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents. Nano Lett 2004; 5(1): 1-4.
28. Peters D, Kastantinc M, Kotamrajua VR, Karmalid PP, Gujratya K, Tirrell M, Ruoslahti E. Targeting atherosclerosis by using modular, multifunctional micelles. Proc Natl Acad Sci USA 2009; 106(24): 9815-9819.
29. Torchilin V. Micellar nanocarriers: pharmaceutical perspectives. Pharm Res 2007; 24(1): 1-16.
30. André JP, Tóth É, Fisher H, Seelig A, Mäcke HR, Merbach AE. High relaxivity for monomeric Gd(DOTA)-based MRI contrast agents, thanks to micellar self-organization. Chem Eur J 1999; 5: 2977-2983.
31. Mulder WJM, Strijkers GJ, Griffioen AW, Bloois L, Molema G, Storm G, Koning GA, Nicolay K. A Liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. Bioconjug Chem 2004; 15: 799-806.
32. Garimella PD, Datta A, Romanini DW, Raymond KN, Francis MB. Multivalent, high-relaxivity MRI contrast agents using rigid cysteine-reactive gadolinium complexes. J Am Chem Soc 2011; 133(37): 14704-14709.
33. Lehn J-M. Supramolecular Chemistry. Wiley-VCH: Weinheim, 1995.
34. Whitesides GM, Grzybowski B. Self-assembly at all scales. Science 2002; 295: 2418-2421.
35. Besenius P, Portale G, Bomans PHH, Janssen HM, Palmans ARA, Meijer EW. Controlling the growth and shape of chiral supramolecular polymers in water. Proc Natl Acad Sci USA 2010; 107(42): 17888-17893.
36. 3-symmetrical molecules in water: the impact of hydrophobic shielding. Chem Eur J 2011; 17: 5193-5203.
37. Caravan P. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 2006; 35(6): 512-523.
38. 17O NMR relaxometric investigations on two gadolinium(III) DTPA-like chelates endowed with high binding affinity to human serum albumin. J Biol Inorg Chem 1999; 4(6): 766-774.
39. Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008; 3(5): 703-717.
40. Kobayashi H, Kawamoto S, Jo S-K, Bryant Jr. HL, Brechbiel MW, Star RA. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. Bioconjug Chem 2003; 14: 388-394.
41. Catana C, Procissi D, Wu Y, Judenhofer MS, Qi J, Pichler BJ, Jacobs RE, Cherry SR. Simultaneous in vivo positron emission tomography and magnetic resonance imaging. Proc Natl Acad Sci USA 2008; 105(10): 3705-3710.
42. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17(9): 2359-2362.